LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | LJP5 | 3 | N23 | 72 | hr | 1476 | 3241 | 3796 | 0.8537 | 0.7807 | |||
SK-BR-3 | LJP5 | 3 | N24 | 72 | hr | 1476 | 2639 | 3796 | 0.6951 | 0.5314 | |||
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 1 | J06 | 72 | hr | 868 | 3512 | 3286 | 1.0687 | 1.0704 |
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 2 | J06 | 72 | hr | 868 | 3827 | 3505 | 1.0917 | 1.0891 |
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 3 | J06 | 72 | hr | 868 | 3570 | 3440 | 1.0377 | 1.0376 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 1 | J05 | 72 | hr | 868 | 3289 | 3286 | 1.0008 | 1.0009 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 2 | J05 | 72 | hr | 868 | 3639 | 3505 | 1.0381 | 1.0375 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 3 | J05 | 72 | hr | 868 | 3210 | 3440 | 0.9331 | 0.9315 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 1 | J04 | 72 | hr | 868 | 3016 | 3286 | 0.9178 | 0.9126 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 868 | 3136 | 3505 | 0.8946 | 0.8924 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 3 | J04 | 72 | hr | 868 | 3031 | 3440 | 0.8810 | 0.8765 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 1 | J03 | 72 | hr | 868 | 2973 | 3286 | 0.9047 | 0.8983 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 2 | J03 | 72 | hr | 868 | 2878 | 3505 | 0.8210 | 0.8134 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 868 | 2927 | 3440 | 0.8508 | 0.8438 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 1 | J02 | 72 | hr | 868 | 2594 | 3286 | 0.7893 | 0.7682 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 2 | J02 | 72 | hr | 868 | 2581 | 3505 | 0.7363 | 0.7179 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 3 | J02 | 72 | hr | 868 | 2699 | 3440 | 0.7845 | 0.7700 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 1 | J01 | 72 | hr | 868 | 1604 | 3286 | 0.4881 | 0.3767 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 2 | J01 | 72 | hr | 868 | 1457 | 3505 | 0.4156 | 0.2932 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 3 | J01 | 72 | hr | 868 | 1461 | 3440 | 0.4247 | 0.2996 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 1 | K06 | 72 | hr | 868 | 2847 | 3429 | 0.8301 | 0.8207 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 2 | K06 | 72 | hr | 868 | 3217 | 3652 | 0.8809 | 0.8813 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 868 | 3457 | 3587 | 0.9637 | 0.9642 |
MDA-MB-231 | AT-7519 | 0.12 | uM | LJP6 | 1 | K05 | 72 | hr | 868 | 2251 | 3429 | 0.6563 | 0.6172 |
MDA-MB-231 | AT-7519 | 0.12 | uM | LJP6 | 2 | K05 | 72 | hr | 868 | 2198 | 3652 | 0.6019 | 0.5655 |